ArisGlobal, a sponsor-backed AI drug development software company, has lost out on two prospective acquisitions. ArisGlobal appears to be trying to address the SaaSpocalypse by building out its agentic platform.
Read the full article: Nordic-Backed ArisGlobal on a Deal Search //
Source: https://www.axios.com/pro/health-tech-deals/2026/06/22/arisglobal-acquisition-deal-nordic